TEAM

Paul Halpern, JD (Managing Member) is the Chief Investment Officer at Versa Capital Management, LLC,  private equity firm with over $1.25 billion under contract.

Scott Dessain, MD, PhD (CSO) is a medical oncologist and immunologist who developed the OCMS technology in his laboratory at the  Lankenau Institute for Medical Research. He co-founded Immunome, Inc. (NASDAQ: IMNM).

Thomas Halpern, (COO) is an expert in project management. As a Marine Captain, he oversaw the movements of over 1,000 Marines and their equipment to 12 sites in 7 Middle Eastern countries.

Rama Devudu Puligedda, PhD (Director of Immunology Research) is an immunologist with over 18 years of experience  and co-inventor of the OCMS technology.  Dr. Puligedda is responsible for the discovery of numerous critical antibodies, including the new international potency standard for inactivated poliovirus vaccines (IPV).